Eli Lilly strikes a $3 billion Chinese drug deal
As Trump wages a trade war, American pharma keeps cutting deals with China.
America Forever Bytes
Company
As Trump wages a trade war, American pharma keeps cutting deals with China.
We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot.
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its blockbuster obesity treatments, Zepbound and Foundayo.
Eli Lilly announced $3.83 billion push into vaccine acquisitions as TMED rose to top T. Rowe Price's ETF lineup last week.
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lill...
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.
Micron Technology joins the $1 trillion club after a historic 19% stock surge. Discover how it overtook giants JPMorgan, Walmart, and Intel.
Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.